Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -168,645 | -105,855 | -47,931 | -182,393 | -137,650 |
| Depreciation Amortization | 1,894 | 1,227 | 586 | 2,061 | 2,690 |
| Income taxes - deferred | -252 | 70 | 403 | -292 | -92 |
| Accounts receivable | -67 | 16 | 38 | 130 | 424 |
| Other Working Capital | 2,623 | 3,847 | -5,949 | 5,902 | 6,157 |
| Other Operating Activity | 37,443 | 23,356 | 6,666 | 23,480 | 12,760 |
| Operating Cash Flow | $-127,004 | $-77,339 | $-46,187 | $-151,112 | $-115,711 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 68,789 | 67,701 | -43,005 | -105,768 | 133,944 |
| PPE Investments | -2,292 | -1,702 | -188 | -5,617 | -5,539 |
| Investing Cash Flow | $66,497 | $65,999 | $-43,193 | $-111,385 | $128,405 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 353,522 | 29,508 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $353,522 | $29,508 |
| Exchange Rate Effect | -515 | -569 | -367 | 376 | 130 |
| Beginning Cash Position | 148,643 | 148,643 | 148,643 | 57,242 | 57,242 |
| End Cash Position | 87,621 | 136,734 | 58,896 | 148,643 | 99,574 |
| Net Cash Flow | $-61,022 | $-11,909 | $-89,747 | $91,401 | $42,332 |
| Free Cash Flow | |||||
| Operating Cash Flow | -127,004 | -77,339 | -46,187 | -151,112 | -115,711 |
| Capital Expenditure | -2,292 | -1,702 | -188 | -5,617 | -5,539 |
| Free Cash Flow | -129,296 | -79,041 | -46,375 | -156,729 | -121,250 |